Particle.news
mRNA Vaccines Clinical Trials Regulatory Affairs Chikungunya Vaccines Investigational Vaccines Chikungunya Vaccine Viral Vaccines Experimental Vaccines Marburg Vaccine Candidates COVID-19 Vaccines Immunotherapy Antiviral Resistance Efficacy Influenza Vaccines HMPV Vaccine H5N1 Vaccines HMPV Vaccine Research H5N1 Vaccine Vaccine Supply Human Health Dengue Vaccine Covid-19 Vaccines Preclinical Research Zika Virus Vaccine Vaccine Regulation Public Health Policy Regulatory Bodies Nipah Virus Vaccine Malaria Vaccines FDA Regulations Immunization Strategies Nasal Vaccines Immune Response Adjuvants Efficacy Testing High-Cost Vaccines mRNA Technology Oral Cholera Vaccine Public Awareness Smallpox Vaccine Clinical Phases Dengue Vaccines CMV Vaccine Efficacy Studies Authorization Human Challenge Trials Jynneos Vaccine
The report ties a roughly 27% plunge in global health funding—driven by abrupt U.S. pullbacks—to a reversal in two decades of gains in child survival.
